GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » 5-Year Yield-on-Cost %

Abionyx Pharma (XPAR:ABNX) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma 5-Year Yield-on-Cost %?

Abionyx Pharma's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Abionyx Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:



XPAR:ABNX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.875
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Abionyx Pharma's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Abionyx Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abionyx Pharma's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abionyx Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Abionyx Pharma's 5-Year Yield-on-Cost % falls into.



Abionyx Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Abionyx Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Abionyx Pharma  (XPAR:ABNX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Abionyx Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Abionyx Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abionyx Pharma (XPAR:ABNX) Business Description

Traded in Other Exchanges
Address
33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma (XPAR:ABNX) Headlines

No Headlines